VALLEY NATIONAL ADVISERS INC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.

Quarter-by-quarter ownership
VALLEY NATIONAL ADVISERS INC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4
-20.0%
1570.0%0.00%0.0%
Q2 2023$5
+25.0%
1570.0%0.00%0.0%
Q1 2023$40.0%1570.0%0.00%0.0%
Q4 2022$4
-99.9%
1570.0%0.00%0.0%
Q3 2022$4,0000.0%1570.0%0.00%0.0%
Q2 2022$4,000
-20.0%
1570.0%0.00%0.0%
Q1 2022$5,0000.0%1570.0%0.00%0.0%
Q4 2021$5,000
-28.6%
1570.0%0.00%0.0%
Q3 2021$7,000
-22.2%
1570.0%0.00%
-50.0%
Q2 2021$9,000
+12.5%
1570.0%0.00%0.0%
Q1 2021$8,000
+14.3%
1570.0%0.00%
+100.0%
Q4 2020$7,000
+40.0%
1570.0%0.00%0.0%
Q3 2020$5,000
-37.5%
1570.0%0.00%
-50.0%
Q2 2020$8,000
+33.3%
1570.0%0.00%0.0%
Q1 2020$6,000
-14.3%
1570.0%0.00%0.0%
Q4 2019$7,000
+40.0%
1570.0%0.00%
+100.0%
Q3 2019$5,000
-37.5%
1570.0%0.00%
-50.0%
Q2 2019$8,000
-27.3%
1570.0%0.00%
-33.3%
Q1 2019$11,000
+57.1%
1570.0%0.00%
+50.0%
Q4 2018$7,000
-41.7%
1570.0%0.00%
-50.0%
Q3 2018$12,000
-7.7%
1570.0%0.00%
-20.0%
Q2 2018$13,0000.0%1570.0%0.01%0.0%
Q1 2018$13,000
+44.4%
1570.0%0.01%
+66.7%
Q4 2017$9,000
-10.0%
1570.0%0.00%0.0%
Q3 2017$10,000
+25.0%
1570.0%0.00%0.0%
Q2 2017$8,000
-11.1%
1570.0%0.00%0.0%
Q1 2017$9,000
+28.6%
1570.0%0.00%0.0%
Q4 2016$7,000
-12.5%
1570.0%0.00%
-25.0%
Q3 2016$8,000
+14.3%
1570.0%0.00%0.0%
Q2 2016$7,000
+16.7%
1570.0%0.00%
+33.3%
Q1 2016$6,000
-40.0%
1570.0%0.00%
-50.0%
Q4 2015$10,000
-9.1%
1570.0%0.01%
-14.3%
Q3 2015$11,000
-35.3%
1570.0%0.01%
-30.0%
Q2 2015$17,000
+13.3%
1570.0%0.01%
+11.1%
Q1 2015$15,0001570.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Eagle Health Investments LP 354,650$18,314,0007.19%
Casdin Capital, LLC 2,165,000$111,801,0003.33%
Rock Springs Capital Management LP 2,543,600$131,352,0002.87%
HealthCor Management, L.P. 1,532,960$79,162,0002.80%
Bellevue Group AG 4,537,092$234,295,0002.48%
Woodline Partners LP 824,097$42,556,0000.94%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,081,347$55,841,0000.83%
Integral Health Asset Management, LLC 43,000$2,221,0000.64%
ArrowMark Colorado Holdings LLC 1,119,566$57,814,0000.43%
Virtus ETF Advisers LLC 18,328$946,0000.40%
View complete list of AGIOS PHARMACEUTICALS INC shareholders